Cansby, E.* et al. GCKIII kinases control hepatocellular lipid homeostasis via shared mode of action. J. Lipid Res. 65:100669 (2024)
Wang, Q.* et al. Ex vivo instability of lipids in whole blood: Preanalytical recommendations for clinical lipidomics studies. J. Lipid Res. 64:100378 (2023)
Anand, S.K.* et al. Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage. J. Lipid Res. 63:100238 (2022)
Grüneis, R.* et al. The kringle IV type 2 domain variant 4925G>A causes the elusive association signal of the LPA pentanucleotide repeat. J. Lipid Res. 63, 11:100306 (2022)
Berger, C.* et al. A novel compound heterozygous leptin receptor mutation causes more severe obesity than in Leprdb/db mice. J. Lipid Res. 62:100105 (2021)
Vvedenskaya, O.* et al. Non-alcoholic fatty liver disease Stratification by Liver Lipidomics. J. Lipid Res. 62:100104 (2021)
Lundsgaard, A.M.* et al. Glucometabolic consequences of acute and prolonged inhibition of fatty acid oxidation. J. Lipid Res. 61, 10-19 (2020)
Ghandour, R.A.* et al. Impact of dietary ω3 polyunsaturated fatty acid supplementation on brown and brite adipocyte function. J. Lipid Res. 59, 452-461 (2018)
Götz, A. et al. Circulating HDL levels control hypothalamic astrogliosis via apoA-I. J. Lipid Res. 59, 1649-1659 (2018)
Mack, S.* et al. A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms. J. Lipid Res. 58, 1834-1844 (2017)
Lattka, E. et al. A common FADS2 promoter polymorphism increases promoter activity and facilitates binding of transcription factor ELK1. J. Lipid Res. 51, 182-191 (2010)
Grallert, H. et al. APOA5 variants and metabolic syndrome in Caucasians. J. Lipid Res. 48, 2614-2621 (2007)
Lingenhel, A.* et al. Role of the kidney in the metabolism of apolipoprotein A-IV: Influence of the type of proteinuria. J. Lipid Res. 47, 2071-2079 (2006)
Koch, W.* ; Mehilli, J.* ; Pfeufer, A. ; Schömig, A.* & Kastrati, A.* Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting. J. Lipid Res. 45, 2221-2226 (2004)
Mohr, M.* et al. Hypercholesterolemia in ENU-induced mouse mutants. J. Lipid Res. 45, 2132-2137 (2004)